Nitric oxide (NO), synthesized by endothelial nitric oxide synthase (eNOS), is the most critical EDRF, and its reduced bioavailability is central to hypertension-related endothelial dysfunction [4]. This evidence concerns the gene NOS3 and endothelial dysfunction.